Dhanvantri Jeevan Rekha Share Price
27.85+1.20 (+4.50%)
+28.34% past 1 Year
Dhanvantri Jeevan Rekha Ltd is a multi speciality hospital providing reliable diagnostic and therapeutical services.The company is basically engaged in offering different medical facilities like Cardiac Care Endourology Gastroenterology Neuro
Corporate filings & documents
Announcements
Newspaper publication for pre agm to update the email id
5 days agoNewspaper publication for pre agm to update the email id
5 days agoRecord Date as per AGM
1 week agoRecord Date as per AGM
1 week agoThe Book closure in respect of AGM
1 week agoThe Book closure in respect of AGM
1 week agoAGM is to be held on 29th September 2026 at 3:00 PM
1 week agoAGM is to be held on 29th September 2026 at 3:00 PM
1 week agoDhanvantri Jeevan Rekha Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2026 inter alia to consider and approve 1AGM and other related compliances.
2 weeks agoDhanvantri Jeevan Rekha Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2026 inter alia to consider and approve 1AGM and other related compliances.
2 weeks agoNewspaper publication
2 weeks agoNewspaper publication
2 weeks agoThe Result for the quarter 30.06.2026
3 weeks agoThe Result for the quarter 30.06.2026
3 weeks agoOutcome of the board meeting
3 weeks agoOutcome of the board meeting
3 weeks agoDhanvantri Jeevan Rekha Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. Quarterly Result
4 weeks agoDhanvantri Jeevan Rekha Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. Quarterly Result
4 weeks agoComplaisance certificate under 74(5)
1 month agoComplaisance certificate under 74(5)
1 month agoThe company is submitting the same in respect of the clarification in regards to Price Movement
2 months agoThe company is submitting the same in respect of the clarification in regards to Price Movement
2 months agoThe Exchange has sought clarification from Dhanvantri Jeevan Rekha Ltd on June 30 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
2 months agoThe Exchange has sought clarification from Dhanvantri Jeevan Rekha Ltd on June 30 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
2 months agoThe trading window closure done for the quarter June 2026
2 months agoThe trading window closure done for the quarter June 2026
2 months agoThe Annual Compliance Report
3 months agoThe newspaper Publication 30
3 months agoThe newspaper Publication 30
3 months agoThe newspaper Publication 30
3 months agoThe newspaper Publication 30
3 months agoresult for year ending 30.03.2026
3 months agoThe Audited Result for the year and quarter ending March 2026
3 months agoDhanvantri Jeevan Rekha Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve To Consider and adopt The Audited Financial Statements for the quarter and year ended on 31st March 2026 along side other matter to be discussed in the meeting
3 months agoCompliance certificate under 74(5) provided by RTA.
4 months agoClosure of trading window March 2026
5 months agoPFA the newsapaper clipping of the result quater ending dec 2025
6 months agoPlease find the result for the dec quarter 2025
6 months agoOutcome of the noard meeting heldon 12-02-2026.
6 months agoDhanvantri Jeevan Rekha Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve To Consider and adopt the unaudited Financial Statement for the quarter ended on 31st December 2025.To authorize the director to publish the unaudited financial statements for the quarter ended on 31st December 2025 pursuant to Regulation 47 of the SEBI Listing Regulation (LOOR 2015).
7 months agocertificate under 74(5)
7 months agoThe trading window is closed for the dec quarter.
8 months agoNews paper Publication
9 months agoRESULT FOR THE YEAR ENDING SEPT 2025
9 months agoMeeting for the quarterly result
9 months agoDhanvantri Jeevan Rekha Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve THE MEETING IS BE HELD FOR QUATERLY RESULT 2025
10 months agoCertificate under 74(5) of SEBI
10 months agoCalrification in respect of Price Movement
11 months agoThe Exchange has sought clarification from Dhanvantri Jeevan Rekha Ltd on October 06 2025 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
11 months agovoting result
11 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
1 Saket Meerut Uttar Pradesh PIN: 250003 Tel No: 0121-2648151 / 2648152 / 2651801 / 9389314915 Fax No: 0121-2651803 Email: [email protected] Internet: www.dhanvantrihospital.in
Registrars
Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi Beetal House , 99 Mandangir 3rd Floor, Behind Local Shopping Centre Near Dada Harsukhdas Mandir PIN: Tel No: 011-29961281 -82 Fax No: 011-29961284 Email: NULL
Management
Shalini Sharma, Managing Director
Meenakshi Elhence, Non Executive Director
Tulsi Prasad Sharma, Non Executive Director
Rowena Sharma, Non Executive Director
Mohd Harris, Non Executive Independent Director
Amitabh Krishna Bhatia, Non Executive Independent Director
Ravi Karan, Non Executive Independent Director
Ritika Bhandari, Company Secretary & Compliance Officer
Premjit Singh Kahsyap, Non Executive Director
Anil Elhence, Non Executive Director
Details
BSE 531043
NSE NULL
ISIN INE239F01015